From: A randomized trial of multivitamin supplementation in children with tuberculosis in Tanzania
Outcome | Time Point (n) a | Placebo | Multivitamins | Hodges-Lehmann | p-valuec |
---|---|---|---|---|---|
 |  | Median (IQR)b | Median (IQR)b | 95% CI |  |
 |  |  |  | (Multivitamin-Placebo) |  |
Hemoglobin, g/dL | Â | Â | Â | Â | |
 | Baseline (251) | 8.70 (7.70, 9.80) | 8.40 (7.40, 9.50) | (-0.20, 0.60) | 0.28 |
 | Final (225) | 9.40 (8.45, 10.25) | 9.60 (8.70, 10.60) | (0.00, 0.70) | 0.05 |
 | Change (223) | 0.40 (-0.30, 1.40) | 1.00 (0.30, 2.30) | (0.30, 1.00) | 0.0001 |
Albumin, g/L | Â | Â | Â | Â | |
 | Baseline (253) | 33.95 (29.90, 38.90) | 34.00 (29.80, 39.10) | (-1.70, 1.70) | 0.92 |
 | Final (232) | 40.20 (36.30, 42.90) | 38.90 (33.80, 42.50) | (-2.70, 0.10) | 0.08 |
 | Change (231) | 4.55 (0.10, 9.60) | 3.40 (0.60, 7.00) | (-2.60, 0.60) | 0.21 |
CD4, cells/μL |  |  |  |  | |
 | Baseline (242) | 1592.50 (1099.00, 2254.00) | 1351.50 (803.00, 2208.50) | (-410.00, 45.00) | 0.11 |
 | Final (212) | 1507.50 (1038.50, 2011.50) | 1410.50 (782.50, 1904.50) | (-373.00, 71.00) | 0.19 |
 | Change (207) | -63.00 (-506.00, 240.00) | -59.50 (-448.00, 261.00) | (-204.00, 140.00) | 0.73 |
CD8, cells/μL |  |  |  |  | |
 | Baseline (242) | 1233.00 (902.00, 2230.00) | 1492.00 (988.00, 2624.00) | (-16.00, 450.00) | 0.06 |
 | Final (212) | 1328.00 (921.50, 2208.50) | 1506.50 (1039.00, 2742.00) | (-98.00, 389.00) | 0.24 |
 | Change (207) | -130.00 (-489.00, 394.00) | -77.50 (-735.00, 432.00) | (-322.00, 193.00) | 0.68 |
CD3, cells/μL |  |  |  |  | |
 | Baseline (242) | 3317.50 (2423.00, 4616.00) | 3593.50 (2430.00, 5211.50) | (-311.00, 590.00) | 0.53 |
 | Final (212) | 3176.00 (2269.00, 4676.50) | 3540.50 (2871.00, 4614.50) | (-154.00, 681.00) | 0.21 |
 | Change (207) | -223.00 (-1149.00, 724.00) | -324.00 (-1179.00, 889.00) | (-519.00, 466.00) | 0.89 |